FDA INSPECTOR SPECIALIZATION IN DEVICE AND DRUG GMPs
This article was originally published in The Gray Sheet
Executive Summary
FDA INSPECTOR SPECIALIZATION IN DEVICE AND DRUG GMPs is planned by the agency, Ronald Johnson, director of the Office of Compliance in FDA's Center for Devices and Radiological Health, said at a June 17 session of the Food and Drug Law Institute's Medical Device Update in Washington, D.C. The FDA field organization is "making plans now to require at some level mandatory training and demonstration of proficiency in particular areas [of specialization] leading to a certificate."
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.